Samuel Truniger

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial

Markus Weber, Boleslaw Goldman, Samuel Truniger · Journal of Neurology Neurosurgery & Psychiatry · 2010 · 113 citations

Medicine, Neurology, Pharmacology +16

Systemic and T cell‐associated responses to <scp>SARS‐CoV</scp>‐2 immunisation in gut inflammation (<scp>STAR SIGN</scp> study): effects of biologics on vaccination efficacy of the third dose of <scp>mRNA</scp> vaccines against <scp>SARS‐CoV</scp>‐2

Simon Woelfel, Joel Dütschler, Marius König et al. · Alimentary Pharmacology & Therapeutics · 2022 · 16 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease

Simon Woelfel, Joel Dütschler, Marius König et al. · Alimentary Pharmacology & Therapeutics · 2023 · 11 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery

Fabian Schnitzler, Matthias Friedrich, Marianne Angelberger et al. · PLoS ONE · 2020 · 10 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease

Simon Woelfel, Joel Dütschler, Daniel Junker et al. · Vaccines · 2024 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17